top of page


I created Railroad Children because I am dedicated to providing individuals and families, affected by rare diseases, with the resources and assistance they need. My experience as a scientist has enabled me to bring a unique perspective to my work. I am passionate about investigating the causes of rare diseases and finding solutions that can help those affected.

Prior to creating Railroad Children, I completed my PhD research on a rare disease called Rett Syndrome, where I investigated the genetic and molecular mechanisms implicated in disease onset and progression. I am also passionate about exploring the fetal origins of rare diseases in relation to neurodevelopment, and I am particularly interested in the impact of early postnatal development and later health issues. Ultimately, I am driven by the goal of making a difference in the lives of individuals and families affected by rare diseases.

  • Facebook
  • Twitter
  • LinkedIn
  • Instagram

My Story

My background is formally in research rare genetic disorders, but I have a broad background in human disease biology. I studied for my BA in Natural Sciences, and my PhD in Biochemistry, at the University of Cambridge, UK. My greatest skills lie in my scientific analytical abilities, and my commitment to hard work.  I have a processing speed in the 99.7th percentile (tested) and I can chomp through masses of complex data from disparate sources and bring that information together to build a full analysis and evaluation of human diseases and the impact of the underlying pathophysiology in an affected individual.  I am passionate about ensuring access to science for all individuals and enjoy helping others to learn about biological phenomena on a molecular, cellular, systems and behavioral level.

My expertise in neurological diseases, makes me uniquely qualified as a rare disease consultant, as over 85% of all rare diseases have severe neurological symptoms. My own research into a condition, called Rett Syndrome, revealed the importance of regulating inflammation in the brain. In my work consulting directly with patients with neurological disorders, it is clear that autoimmune diseases, and metabolic dysfunction play a primary role in the emergence of symptoms such as cognitive impairment, motor dysfunction, seizure control and memory loss.  In many cases, repurposing drugs that target metabolism and inflammation resulted in a robust improvement of symptoms for the individual client.

Aside from my rare disease work, I work as a Biotech Consultant, where I provide my clients with a multidisciplinary approach to solving challenges they face at the scientific and strategy level of drug and biodevices development.  I specialize in five main areas which are crucial to the development of successful biotech companies.  These  areas include product design, (mainly drug development), competitive business strategy, diagnostic tool development, novel research approaches, and safety procedures.  Over the last three years, I have expanded my capabilities to include the preparation and submission of FDA IND applications, and IRB approval for clients who are using human tissues, experimental animals, or who are entering the clinical trials phase.

One of the key roles I fullfill for my clients is to provide guidance on the design and execution of preclinical studies. In this role, I advise on appropriate research design and interpretation of data to ensure that the results are robust and accurate.   By addressing the diverse needs of my clients I have gained significant experience in evaluating drug development strategy, troubleshooting underperforming areas in the drug development pipeline, and restructuring the preclinical R&D approach in line with the client’s financial circumstances. In all my projects I am committed to the establishment of procedures for checks and balances to ensure R&D targets are met, and that patient safety is upheld, while ensuring that access to unique treatment solutions is maintained.


I'm always looking for new and exciting opportunities. Let's connect.

bottom of page